Relay Therapeutics Inc. (RLAY)
NASDAQ: RLAY
· Real-Time Price · USD
3.04
-0.23 (-7.03%)
At close: Jun 17, 2025, 3:59 PM
3.02
-0.82%
After-hours: Jun 17, 2025, 07:41 PM EDT
-7.03% (1D)
| Bid | 3 |
| Market Cap | 522.05M |
| Revenue (ttm) | 7.68M |
| Net Income (ttm) | -333.39M |
| EPS (ttm) | -2.2 |
| PE Ratio (ttm) | -1.38 |
| Forward PE | -1.79 |
| Analyst | Buy |
| Ask | 3.45 |
| Volume | 1,284,658 |
| Avg. Volume (20D) | 2,329,260 |
| Open | 3.27 |
| Previous Close | 3.27 |
| Day's Range | 3.04 - 3.29 |
| 52-Week Range | 1.77 - 10.72 |
| Beta | 1.59 |
About RLAY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RLAY
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RLAY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-5.12%
Relay Therapeutics shares are trading lower follow...
Unlock content with
Pro Subscription
6 months ago
+12.42%
Relay Therapeutics shares are trading higher after the company announced updated interim clinical data for RLY-2608.
